Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$123.90

6.35 (5.40%)

07:55
06/14/19
06/14
07:55
06/14/19
07:55

Bluebird Bio to hold a conference call

Management provides additional updates for Zynteglo/lentiglobin, as presented at the 24th Congress of EHA, on a conference call to be held on June 14 at 8 am. Webcast Link

  • 14

    Jun

BLUE Bluebird Bio
$123.90

6.35 (5.40%)

05/17/19
JPMS
05/17/19
NO CHANGE
Target $195
JPMS
Overweight
Bluebird Bio 20% pullback since early April brings opportunity, says JPMorgan
JPMorgan analyst Cory Kasimov thinks investors should use times of share weakness to buy or add to longer-term positions in Bluebird Bio. With the stock off nearly 20% since early April, "this could be one of those times," Kasimov tells investors in a research note. He believes Bluebird has a relatively high likelihood of going four-for-four with its initial late-stage shots on goal. The analyst maintains an Overweight rating on the shares with a $195 price target.
05/16/19
RHCO
05/16/19
NO CHANGE
Target $174
RHCO
Buy
Bluebird Bio price target lowered to $174 from $184 at SunTrust
SunTrust analyst Edward Nash lowered his price target on Bluebird Bio to $174 to reflect the changes in his model after the company's Analyst Day presentation. The analyst is pushing back his expected Lenti-D start year to 2020 from 2019 and also raising his assumed R&D and SG&A expenses while also removing the revenue projections for the company's B-thalassemia patients aged below 12 in the U.S. and E.U. Nash is also keeping his Buy rating on Bluebird Bio, saying he sees the company as "best positioned" in transforming gene therapy from a "scientific endeavor" to a "successful proposition."
05/15/19
05/15/19
DOWNGRADE
Target $131

Neutral
Bluebird Bio downgraded to Neutral at Wedbush on ZYNTEGLO launch risks
As previously reported, Wedbush analyst David Nierengarten downgraded Bluebird Bio to Neutral from Outperform after attending the company's Analyst Day, as he sees risks to the ZYNTEGLO launch that could overshadow its broad pipeline. Specifically, the analyst now expects installment, performance-based pricing of $320,000/year, in-line with annual treatment costs, for 5 years, or $1.6M total, with a 15% discount on the total potential price as some patients will not fully respond/meet the performance requirements. With installment pricing, Nierengarten incorporates additional financing in his model as it creates an "air gap" for cash flow that the company will have to fill before it becomes cash flow positive. The analyst also lowered his price target on the shares to $131 fr0m $166.
05/15/19
WEDB
05/15/19
DOWNGRADE
WEDB
Neutral
Bluebird Bio downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

RCL

Royal Caribbean

$114.85

-3.94 (-3.32%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
Royal Caribbean, ITM Group partner to form new destination company »

Royal Caribbean and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTYH

GTY Technology Holdings

$7.64

-0.26 (-3.29%)

08:01
06/24/19
06/24
08:01
06/24/19
08:01
Hot Stocks
GTY Technology Holdings announces cooperative contract with Texas DIR »

GTY Technology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$74.34

0.94 (1.28%)

07:59
06/24/19
06/24
07:59
06/24/19
07:59
Hot Stocks
Alnylam presents new ONPATTRO results at 2019 PNS meeting »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

, UNH

UnitedHealth

$252.31

4.53 (1.83%)

07:57
06/24/19
06/24
07:57
06/24/19
07:57
Recommendations
HMS Holdings, UnitedHealth analyst commentary  »

HMS Holdings' recent…

HMSY

HMS Holdings

$31.86

-0.71 (-2.18%)

UNH

UnitedHealth

$252.31

4.53 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Jul

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Caesars to adjourn Annual Meeting of shareholders »

Caesars Entertainment…

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

TTPH

Tetraphase

$0.63

-0.02 (-3.10%)

07:56
06/24/19
06/24
07:56
06/24/19
07:56
Hot Stocks
Tetraphase presents new Xerava data at ASM »

Tetraphase announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

07:53
06/24/19
06/24
07:53
06/24/19
07:53
Initiation
Concert Pharmaceuticals initiated  »

SunTrust starts Concert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

WAB

Wabtec

$72.75

0.42 (0.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Downgrade
Wabtec rating change  »

Wabtec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHSP

SharpSpring

$12.84

-0.34 (-2.58%)

07:52
06/24/19
06/24
07:52
06/24/19
07:52
Upgrade
SharpSpring rating change  »

SharpSpring upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$85.58

2.55 (3.07%)

07:50
06/24/19
06/24
07:50
06/24/19
07:50
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Sep

BARZ

5Barz

$0.00

(0.00%)

07:49
06/24/19
06/24
07:49
06/24/19
07:49
Hot Stocks
5Barz signs agreement with Kaynes Technology for Network Extender in India »

5BARz International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Earnings
LiveRamp raises FY20 revenue view to $363M-$377M from $358M-$372M »

Consensus $366.45M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBIX

Ebix

$47.71

0.48 (1.02%)

07:47
06/24/19
06/24
07:47
06/24/19
07:47
Hot Stocks
Ebix expands A.D.A.M. Health Services business with client wins »

Ebix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$5.72

-0.07 (-1.21%)

07:46
06/24/19
06/24
07:46
06/24/19
07:46
Downgrade
Oasis Petroleum rating change  »

Oasis Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAMP

LiveRamp

$51.13

-1.135 (-2.17%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
LiveRamp to acquire Data Plus Math »

LiveRamp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMHTF

Emerald Health Therapeutics

$0.00

(0.00%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Emerald Health receives cultivation license for cannabis operation in BC »

Emerald Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$9.99

-0.05 (-0.50%)

, ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

07:44
06/24/19
06/24
07:44
06/24/19
07:44
Hot Stocks
Icahn says 'pleased' with Caesars, Eldorado Resorts planned merger »

Carl Icahn said, …

CZR

Caesars

$9.99

-0.05 (-0.50%)

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

VLRX

Valeritas

$2.85

0.025 (0.88%)

07:43
06/24/19
06/24
07:43
06/24/19
07:43
Hot Stocks
Valeritas sells over 20M V-Go insulin delivery devices in the U.S. »

Valeritas Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

, CZR

Caesars

$9.99

-0.05 (-0.50%)

07:42
06/24/19
06/24
07:42
06/24/19
07:42
Conference/Events
Eldorado Resorts to host conference call »

Conference call to…

ERI

Eldorado Resorts

$51.22

-1.48 (-2.81%)

CZR

Caesars

$9.99

-0.05 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

ALO

Alio Gold

$0.72

-0.0004 (-0.06%)

07:42
06/24/19
06/24
07:42
06/24/19
07:42
Hot Stocks
Alio Gold says ISS, Glass Lewis recommend shareholders vote for propsals »

Alio Gold announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$24.17

-1.11 (-4.39%)

07:40
06/24/19
06/24
07:40
06/24/19
07:40
Hot Stocks
Axsome Therapeutics initiates GEMINI Phase 3 trial of AXS-05 »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$50.62

-0.7 (-1.36%)

, APC

Anadarko

$70.37

-0.1 (-0.14%)

07:40
06/24/19
06/24
07:40
06/24/19
07:40
Downgrade
Occidental Petroleum, Anadarko rating change  »

Occidental Petroleum…

OXY

Occidental Petroleum

$50.62

-0.7 (-1.36%)

APC

Anadarko

$70.37

-0.1 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

BAESY

BAE Systems

$0.00

(0.00%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Hot Stocks
BAE Systems awarded $90M Navy contract for C5ISR systems »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$8.67

-0.83 (-8.74%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Hot Stocks
Applied Therapeutics initiates Phase 1/2 sstudy of AT-007 »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NERV

Minerva

$4.23

0.03 (0.71%)

07:39
06/24/19
06/24
07:39
06/24/19
07:39
Conference/Events
Minerva to hold a conference call »

Chairman & CEO, Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.